UK drugmaker AstraZeneca profit slumps but sales jump
AstraZeneca's first-quarter net profit dropped due to restructuring and legal costs associated...
On Wednesday, British drugmaker AstraZeneca announced that it had withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing “commercial reasons” and a surplus of updated jabs.
An AstraZeneca spokesperson stated, “As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.”
Catch all the International News, Breaking News Event and Latest News Updates on The BOL News
Download The BOL News App to get the Daily News Update & Follow us on Google News.